Table 1 GAGE applied to the two lung cancer datasets of large sample sizes

Experimental Sets

p-val

q-val

Notes

Experimental Sets

p-val

q-val

Notes

Tarte_Plasma_Blastic

1.8E-64

1.1E-61

c

Tarte_Plasma_Blastic

5.6E-42

4.1E-39

c

Uvb_Nhek3_All

1.2E-59

3.6E-57

t

Cancer_Undifferentiat

1.0E-22

3.8E-20

bt

Peng_Glutamine_Dn

3.7E-59

7.6E-57

c

Brca_Er_Neg

8.3E-19

2.0E-16

bt

Lei_Myb_Regulated_G

5.8E-55

8.8E-53

bt, c

Serum_Fibroblast_Cell

3.2E-18

5.9E-16

bt, c

Peng_Leucine_Dn

4.0E-42

4.8E-40

c

Uvb_Nhek3_All

5.3E-17

7.7E-15

t

Cancer_Undifferentiat

3.0E-41

3.0E-39

bt

Caries_Pulp_Up

4.7E-16

4.6E-13

Brca_Er_Neg

2.0E-40

1.7E-38

bt

Zhan_Mm_Cd138_Pr_

8.3E-15

1.0E-12

bt

Peng_Rapamycin_Dn

3.5E-38

2.7E-36

c

Li_Fetal_Vs_Wt_Kidne

3.7E-14

3.8E-12

t

Rcc_Nl_Up

5.2E-36

3.5E-34

t

Dox_Resist_Gastric_Up

1.2E-13

1.1E-11

bt

Cancer_Neoplastic_Me

4.2E-35

2.6E-33

t

Idx_Tsa_Up_Cluster3

2.4E-13

1.9E-11

c

Canonical Pathways

p-val

q-val

Notes

Canonical Pathways

p-val

q-val

Notes

Gpcrs_Class_A_Rhod

9.2E-23

3.1E-20

bt

Gpcrs_Class_A_Rhod

3.1E-10

1.0E-07

bt

Gpcrdb_Class_A_Rho

4.7E-21

7.8E-19

bt

Gpcrdb_Class_A_Rho

1.1E-09

1.9E-07

bt

Blood_Clotting_Casca

5.1E-15

4.7E-13

bt

Androgen_Genes

5.2E-08

5.8E-06

bt

Intrinsicpathway

6.3E-15

5.3E-13

bt

Cytokinepathway

1.9E-07

1.6E-05

bt

Fibrinolysispathway

1.1E-12

9.1E-11

bt

Prostaglandin_And_Le

2.9E-05

2.4E-03

bt

Peptide_Gpcrs

1.9E-12

1.6E-10

bt

Proliferation_Genes

5.1E-05

4.3E-03

c

Tyrosine_Metabolism

8.7E-09

7.3E-07

bt

Peptide_Gpcrs

5.8E-05

4.8E-03

bt

Extrinsicpathway

5.5E-07

4.6E-05

bt

Intrinsicpathway

9.1E-05

7.6E-03

bt

Gpcrdb_Other

5.2E-06

4.4E-04

bt

Androgen_And_Estrog

4.2E-04

3.4E-02

bt

Small_Ligand_Gpcrs

6.7E-06

5.6E-04

bt

Blood_Clotting_Casca

7.5E-04

5.9E-02

bt